Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 0 | 0 | 1 | 2 | 0 |
| Gross Profit | N/A | 0 | 1 | 2 | 0 |
| Operating Expenses | 15 | 15 | 30 | 34 | 45 |
| Operating Income | -18 | -15 | -30 | -32 | -45 |
| Interest Expense | 0 | 39 | 76 | 13 | 40 |
| Other Income | 127 | 0 | 1 | 0 | 0 |
| Pre-tax Income | 109 | -54 | -105 | -45 | -85 |
| Net Income Continuous | 108 | -54 | -105 | -45 | -85 |
| Net Income | $108 | $-54 | $-105 | $-45 | $-85 |
| EPS Basic Total Ops | -12.99 | -6.49 | -12.99 | -6.49 | -12.99 |
| EPS Basic Continuous Ops | -13.93 | -6.59 | -12.89 | -5.55 | -10.43 |
| EPS Diluted Total Ops | -12.99 | -6.49 | -12.99 | -6.49 | -12.99 |
| EPS Diluted Continuous Ops | -13.93 | -6.59 | -12.89 | -5.55 | -10.43 |
| EBITDA(a) | $-20 | $-13 | $-28 | $-31 | $-41 |